文献速递胰腺与胆道疾病消化内镜

经内镜逆行胰胆管造影相关穿孔的管理:一项大型多中心研究

Management of ERCP-related perforation: a large multicenter study.
PubMed 文献 · Gastrointest Endosc · 2024-12-15

该研究回顾性分析了日本21家三级医院2017年4月至2022年3月间51,957例经内镜逆行胰胆管造影(ERCP)患者中58例(0.12%)ERCP相关十二指肠穿孔的特征与结局。按Stapfer分型评估,内镜治疗组住院时间和愈合时间显著短于手术组,内镜治疗和术中诊断与良好临床病程独立相关。

要点

  • ERCP相关十二指肠穿孔发生率为0.12%(58/51,957),平均住院时间27.1天,死亡率2%。
  • 内镜治疗患者住院时间(P=.031)和愈合时间(P=.009)显著短于手术治疗患者。
  • 内镜治疗(P=.017)和术中诊断(P=.019)与良好临床病程独立相关。

核心结论

  • 在ERCP操作过程中诊断穿孔可预防严重不良事件,应仔细审阅透视和内镜图像。
  • 对于ERCP操作期间诊断穿孔的患者,内镜管理应作为首选治疗。

研究设计与样本

  • 回顾性研究,评估日本21家三级医院2017年4月至2022年3月间接受ERCP的51,957例患者中ERCP相关十二指肠穿孔的发生率。
  • 按Stapfer分类系统对ERCP相关十二指肠穿孔进行分型,按损伤机制、诊断时间和治疗方式评估严重不良事件、住院时间(LOS)和死亡率。

主要发现

  • 51,957例接受ERCP的患者中,58例(0.12%)发生ERCP相关十二指肠穿孔。
  • 平均住院时间为27.1天,死亡率为2%。
  • 内镜治疗患者住院时间(P=.031)和愈合时间(P=.009)显著短于手术治疗患者。
  • 多因素Cox回归分析显示,内镜治疗(P=.017)和术中诊断(P=.019)与良好临床病程独立相关。

关键数值与推荐

  • ERCP相关十二指肠穿孔按Stapfer分类系统分型。
  • 内镜治疗患者住院时间显著短于手术治疗患者(P=.031)。
  • 内镜治疗患者愈合时间显著短于手术治疗患者(P=.009)。
  • 多因素Cox回归分析:内镜治疗(P=.017)和术中诊断(P=.019)与良好临床病程独立相关。

临床怎么用

  • 在ERCP操作过程中应仔细审阅透视和内镜图像以诊断穿孔。
  • 对于ERCP操作期间诊断穿孔的患者,作者认为内镜管理应作为首选治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Perforation is a rare but serious adverse event associated with ERCP. There is no consensus to guide clinicians in the management of ERCP-related duodenal perforations, making it difficult to determine whether surgical or endoscopic treatment is optimal. The present study retrospectively evaluated the characteristics and clinical outcomes of patients who experienced ERCP-related duodenal perforations according to the mechanism of injury. METHODS: This study evaluated the incidence of ERCP-related duodenal perforations among 51,957 patients who underwent ERCP at 21 tertiary care hospitals in Japan between April 2017 and March 2022. ERCP-related duodenal perforations were categorized according to the Stapfer classification system. Serious adverse events, length of stay (LOS), and mortality associated with ERCP-related duodenal perforations were evaluated according to the mechanism of injury, time of diagnosis, and treatment modality. RESULTS: Of 51,957 patients who underwent ERCP, 58 (.12%) experienced ERCP-related duodenal perforations. The mean LOS was 27.1 days, and the mortality rate was 2%. LOS (P = .031) and time to healing (P = .009) were significantly shorter in patients who underwent endoscopic than surgical treatment. Multivariate Cox regression analysis showed that endoscopic treatment (P = .017) and intraprocedural diagnosis (P = .019) were independently associated with a good clinical course. CONCLUSIONS: Diagnosing a perforation during the ERCP procedure can prevent serious adverse events. Fluoroscopic and endoscopic images should be carefully reviewed. Endoscopic management should be the treatment of choice for patients diagnosed with perforation during ERCP procedures.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Emori T, Yamasaki T, Itonaga M, et al. Management of ERCP-related perforation: a large multicenter study. Gastrointest Endosc. 2024. PMID: 39689733. doi:10.1016/j.gie.2024.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。